The effect of antiplatelet autoantibodies on megakaryocytopoiesis

International Journal of Hematology

Volumn 81, Issue 2, 2005, Pages 94-99

  McMillan, Robert ^a   Nugent, Diane ^b  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b CHILDREN S HOSPITAL OF ORANGE COUNTY   (United States)

Author keywords

Antiplatelet antibody; Immune thrombocytopenia; ITP

Indexed keywords

AUTOANTIBODY; THROMBOCYTE ANTIBODY;

CELL CULTURE; CELL DAMAGE; CELL DESTRUCTION; CELL MATURATION; COLONY FORMING CELL; DRUG EFFECT; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IN VITRO STUDY; IN VIVO STUDY; INFUSION; MEGAKARYOCYTE; MEGAKARYOPOIESIS; PATHOGENESIS; REVIEW; THROMBOCYTE COUNT; THROMBOCYTE LYSIS; THROMBOCYTE TURNOVER; THROMBOCYTOPENIA; THROMBOCYTOPOIESIS; TURNOVER TIME; ULTRASTRUCTURE;

AUTOANTIBODIES; BLOOD PLATELETS; HUMANS; PURPURA, THROMBOCYTOPENIC, IDIOPATHIC; THROMBOPOIESIS;

EID: 13944266670     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1532/IJH97.04168     Document Type: Review

References (34)

1. Frank E. Die essentielle Thrombopenie. (Konstitutionelle Purpura-Pseudohämophilie), I: Klinische Bild. Berl Klin Wochenschr. 1915; 52:454-458.
2. Kaznelson P. Verschwinden der hämorrhagischen Diathese bei einem Falle von "essentieller Thrombopenie" (Frank) nach Milzex-stirpation: Splenogene thrombolytische Purpura. Wien Klin Wochenschr. 1916;29:1451-1454.
3. Harrington WJ, Sprague CC, Minnich V, Moore CV, Aulvin RC, Dubach R. Immunologic mechanisms in idiopathic and neonatal thrombocytopenic purpura. Ann Intern Med. 1953;38:433-469.
4. Shulman NR, Marder VJ, Weinrach RS. Similarities between known antiplatelet antibodies and the factor responsible for thrombocytopenia in idiopathic purpura: physiologic, serologic, and isotopic studies. Ann N Y Acad Sci. 1965;124:499-542.
5. McMillan R. Autoantibodies and autoantigens in chronic immune thrombocytopenic purpura. Semin Hematol. 2000;37:239-248.
6. Firkin BG, Wright R, Miller S, Stokes E. Splenic macrophages in thrombocytopenia. Blood. 1969;33:240-245.
7. McMillan R, Longmire RL, Tavassoli M, Armstrong S, Yelenosky R. In vitro platelet phagocytosis by ITP splenic leukocytes in idiopathic thrombocytopenic purpura. N Engl J Med. 1974;290: 249-251.
8. Tsubakio T, Kurata Y, Kanayama Y, Yonezawa T, Tarui S, Kitani T. In vitro platelet phagocytosis in idiopathic thrombocytopenic purpura. Acta Haematol. 1983;70:250-256.
9. Hauch TW, Rosse WF. Platelet-bound complement (C3) in immune thrombocytopenia. Blood. 1977;50:1129-1136.
10. Tsubakio T, Tani P, Curd JG, McMillan R. Complement activation in vitro by antiplatelet antibodies in chronic immune thrombocytopenic purpura. Br J Haematol. 1986;63:293-300.
11. Vainchenker W, Deschamps JF, Bastin JM, et al. Two monoclonal antiplatelet antibodies as markers of human megakaryocyte maturation: immunofluorescent staining and platelet peroxidase detection in megakaryocyte colonies and in in vivo cells from normal and leukemic patients. Blood. 1982;59:514-521.
12. McKenna JL, Pisciotta AV. Fluorescence of megakaryocytes in idiopathic thrombocytopenic purpura (ITP) stained with fluorescent antiglobulin serum. Blood. 1962;19:664-674.
13. Joshi BC, Jain NC. Detection of antiplatelet antibody in serum and on megakaryocytes of dogs with autoimmune thrombocytopenia. Am J Vet Res. 1976;37:681-685.
14. McMillan R, Luiken GA, Levy R, Yelenosky R, Longmire RL. Antibody against megakaryocytes in idiopathic thrombocytopenic purpura. JAMA. 1978;239:2460-2462.
15. Dameshek W, Miller EB. The megakaryocytes in idiopathic thrombocytopenic purpura, a form of hypersplenism. Blood. 1946;1: 27-52.
16. Diggs LW, Hewlett JS. A study of the bone marrow from thirty-six patients with idiopathic hemorrhagic (thrombopenic) purpura. Blood. 1948;3:1090-1104.
17. Pisciotta AV, Stefanini M, Dameshek W. Studies on platelets, X: morphologic characteristics of megakaryocytes by phase contrast microscopy in normals and in patients with idiopathic thrombocytopenic purpura. Blood. 1953;8:703-723.
18. Stahl CP, Zucker-Franklin D, McDonald TP. Incomplete antigenic cross-reactivity between platelets and megakaryocytes: relevance to ITP. Blood. 1986;67:421-428.
19. Houwerzijl EJ, Blom NR, van der Want JJL, et al. Ultrastructural study shows morphological features of apoptosis and para-apoptosis in megakaryocytes from patients with idiopathic thrombocytopenic purpura. Blood. 2004;103:500-506.
20. Heyns AP, Lotter MG, Badenhorst PN, et al. Kinetics and sites of destruction of 111Indium-oxine-labeled platelets in idiopathic thrombocytopenic purpura: a quantitative study. Am J Hematol. 1982;12:167-177.
21. Stoll D, Cines DB, Aster RH, Murphy S. Platelet kinetics in patients with idiopathic thrombocytopenic purpura and moderate thrombocytopenia. Blood. 1985;65:584-588.
22. Heyns AP, Badenhorst PN, Lotter MG, Pieters H, Wessels P, Kotze HF. Platelet turnover and kinetics in immune thrombocytopenic purpura: results with autologous 111In-labeled and homologous 51Cr-labeled platelets differ. Blood. 1986;67:86-92.
23. Ballem PJ, Segal GM, Stratton JR, Gernsheimer T, Adamson JW, Slichter S. Mechanisms of thrombocytopenia in chronic autoimmune thrombocytopenic purpura: evidence for both impaired platelet production and increased platelet clearance. J Clin Invest. 1987;80:33-40.
24. Bellucci S, Han ZC, Caen JP. Studies of in vitro megakaryocytopoiesis in adult immune thrombocytopenic purpura (ITP). Eur J Haematol. 1991;47:86-90.
25. Abgrall J, Berthou C, Sensebe L, Le Niger C, Escoffre M. Decreased in vitro megakaryocyte colony formation in chronic idiopathic thrombocytopenic purpura. Br J Haematol. 1993;85: 803-804.
26. Hoffman R, Mazur E, Bruno E, Floyd V. Assay of an activity in the serum of patients with disorders of thrombopoiesis that stimulates formation of megakaryocytic colonies. N Engl J Med. 1981;305: 533-538.
27. Chang M, Nakagawa PA, Williams SA, et al. Immune thrombocytopenic purpura (ITP) plasma and purified ITP monoclonal autoantibodies inhibit megakaryocytopoiesis in vitro. Blood. 2003; 102:887-895.
28. Takahashi R, Sekine N, Nakatake T. Influence of monoclonal antiplatelet glycoprotein antibodies on in vitro human megakaryocyte colony formation and proplatelet formation. Blood. 1999;93: 1951-1958.
29. Zauli G, Catani L, Gibellini D, et al. Impaired survival of bone marrow GPIIb/IIa+ megakaryocytic cells as an additional pathogenetic mechanism of HIV-1-related thrombocytopenia. Br J Haematol. 1996;92:711-717.
30. Zauli G, Vitale M, Falcieri E, et al. In vitro senescence and apoptotic cell death of human megakaryocytes. Blood. 1997;90: 2234-2243.
31. McMillan R, Wang L, Tomer A, Nichol J, Pistillo J. Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult chronic ITP patients. Blood. 2004;103:1364-1369.
32. Nugent DJ, Kunicki TJ. Autoimmune thrombocytopenic purpura. In: Theofilopoulos A, Bona C, eds. The Molecular Pathology of Autoimmune Diseases. New York, NY: Taylor & Francis; 2002: 543-566.
33. + cells are correlated with different levels of platelet release. Blood. 2002;99:888-897.
34. Olsson B, Andersson P, Jernas M, et al. T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura. Nat Med. 2003;9:1123-1124.